FTAI Aviation Ltd vs Heron Therapeutics Inc — how do they compare? FTAI Aviation Ltd trades at $229.74 (market cap $23.17B), while Heron Therapeutics Inc trades at $0.33 (market cap $61.47M). The key difference: FTAI Aviation Ltd is far larger — about 376.9× Heron Therapeutics Inc's market cap, and FTAI Aviation Ltd pays a 0.89% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| FTAI | HRTX | |
|---|---|---|
Market Cap | $23.17B | $61.47M |
Sector | Industrials | Health |
52-Week High | $310.04 | $1.49 |
52-Week Low | $140.40 | $0.32 |
Enterprise Value | $26.29B | $168.21M |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.
The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.
Trailing returns across standard periods
Latest headlines on both assets
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →